Paul R. Edick - Chairman and Chief Executive Officer, Director at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and Chief Executive Officer, Director
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul R. Edick since 05 Mar 2025

Holdings reported by Paul R. Edick for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,788,064 $7,083,680 $1.87 31 Jan 2024 Direct
Common Stock 33,430 $62,514 $1.87 31 Jan 2024 By: Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018
Stock Appreciation Right 500,000 31 Jan 2024 Direct Common Stock

Transactions reported by Paul R. Edick for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.